Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also ...

A HALF-HOUR scan could help bladder cancer patients be treated almost twice as fast, a groundbreaking study has found. Using ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

Discover recent advancements in near-infrared fluorescence imaging that have revolutionised lymph node tracing in cancers ...

Innovative fluorescence-based diagnostic system identifies early-stage bladder cancer with 90% accuracy, utilizing untreated ...

Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering hope to thousands of patients.

Tony Hunter, PhD “In bladder cancer, our work shows that PIN1 is ... which contribute to the tumor tissue stromal architecture and to the survival and proliferation of the tumor cells.

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

Taking a combination of two drugs including statins could lower cholesterol - and slow the progression of a common cancer, ...

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring.

A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for ...

A combination therapy of two drugs — a statin and a protein inhibitor — may help suppress the creation and growth of tumors ...